Portal Medical has a large number of granted and pending patents in a large geographical area. The company has patents filed in 13 territories (excluding individual European filings) with a total of 27 granted patents. The company is expanding its patent portfolio to include coating and surface modifications of individual components within an inhalation device.
The company strategy is to develop intellectual property primarily for the inhalation market and identify partners to licence and commercialise the technology.
Portal Medical Ltd has entered into an exclusive license with Presspart Manufacturing Ltd for fluorocarbon coating/modification of aluminium pressurised metered dose inhaler canister.